Epidermolysis bullosa pruriginosa responding to dupilumab-Reference-Cited by-同舟云学术

Epidermolysis bullosa pruriginosa responding to dupilumab

Published:2021-10 Issue: Volume:16 Page:69-71
ISSN:2352-5126
Container-title:JAAD Case Reports
language:en
Short-container-title:JAAD Case Reports

Author:

Clawson Rebecca C.,Duran Stephan F.,Pariser Robert J.

Publisher

Elsevier BV

Subject

Dermatology

Reference10 articles.

1. Human type VII collagen: genetic linkage of the gene (COL7A1) on chromosome 3 to dominant dystrophic epidermolysis bullosa;Ryynänen;Am J Hum Genet,1991

2. Epidermolysis bullosa pruriginosa;Cambiaghi;Dermatology,1997

3. Refining Genotype-Phenotype Correlation in Epidermolysis Bullosa. Dissertation;Al-Maani,2017

4. Successful treatment of epidermolysis bullosa pruriginosa with topical tacrolimus;Banky;Arch Dermatol,2004

5. Epidermolysis bullosa pruriginosa - report of three cases;Das;Indian J Dermatol Venereol Leprol,2005

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib;JAMA Dermatology;2024-08-21

2. Novel variant c.7795-1G>A of COL7A1 gene in a 12-month-old female child with recessive dystrophic epidermolysis bullosa treated with dupilumab;JAAD Case Reports;2024-08

3. Unveiling the value of C‐reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross‐sectional study;Experimental Dermatology;2024-07-29

4. Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin;British Journal of Dermatology;2024-03-13

5. IL‐6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: A prospective cohort study;Journal of the European Academy of Dermatology and Venereology;2024-02-20